The provided document is a security advisory from Oracle, detailing the Critical Patch Update for January 2023. It includes a risk matrix that lists vulnerabilities addressed in the update.

Based on the advisory, CVE-2023-21891 is related to Oracle Business Intelligence Enterprise Edition, specifically its Visual Analyzer component.

Here's a breakdown of the relevant information:

**Vulnerability:** CVE-2023-21891

*   **Component:** Oracle Business Intelligence Enterprise Edition - Visual Analyzer
*   **Affected Versions:** 5.9.0.0.0, 6.4.0.0.0
*  **CVSS Base Score:** 5.4
*   **Attack Vector:** Network
*   **Attack Complexity:** Low
*   **Privileges Required:** Required
*   **User Interaction:** Changed
*   **Scope:** Unchanged
*   **Confidentiality:** Low
*   **Integrity:** Low
*  **Availability:** None

**Root Cause:** The root cause is not explicitly mentioned, but it is related to the Visual Analyzer component of Oracle Business Intelligence Enterprise Edition.

**Weaknesses/Vulnerabilities:** The vulnerability allows an attacker to impact the confidentiality and integrity of the affected system but not its availability.

**Impact of Exploitation:** Successful exploitation could lead to a compromise of confidentiality and integrity. It does not directly cause availability issues.

**Attack Vectors:** The attack vector is through the network, suggesting remote exploitation.

**Required Attacker Capabilities/Position:**
*   The attacker needs to have network access to the vulnerable service.
*   The attacker requires some level of privileges on the target system to exploit the vulnerability.

**Additional Notes:**
*   The advisory indicates that the vulnerability may be remotely exploitable over a network, but it requires user credentials/privileges to exploit it.
*   The impact is listed as "Low" for confidentiality and integrity and "None" for availability.
*   The "User Interaction" is "Changed"

This information is extracted from the risk matrix and related information of the Oracle Critical Patch Update Advisory for January 2023.